GeneDx Holdings (WGS) Enterprise Value (2020 - 2026)
GeneDx Holdings (WGS) posted quarterly Enterprise Value of -$170.7 million for Q1 2026, down 7.24% year-over-year from -$184.0 million in Q1 2025, and little changed quarter-over-quarter from -$171.3 million in Q4 2025.
GeneDx Holdings (WGS) Enterprise Value (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Enterprise Value for 7 consecutive years, with -$170.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 7.24% year-over-year to -$170.7 million; the TTM figure through Mar 2026 stood at -$170.7 million (down 7.24% YoY), while the FY2025 annual figure was -$171.3 million, down 21.32% from the prior year.
- Enterprise Value steadied at -$170.7 million in Q1 2026 per WGS's latest filing, from -$171.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$106.9 million in Q2 2024 and bottomed at -$315.0 million in Q1 2022.
- Historically, Enterprise Value has averaged -$164.6 million across 5 years, with a median of -$155.1 million in 2025.
- On a YoY basis, Enterprise Value climbed as much as 69.06% in 2022 and fell as far as 973.92% in 2022.
- GeneDx Holdings' Enterprise Value stood at -$123.9 million in 2022, then decreased by 5.01% to -$130.1 million in 2023, then declined by 8.48% to -$141.2 million in 2024, then retreated by 21.32% to -$171.3 million in 2025, then grew by 0.35% to -$170.7 million in 2026.
- Business Quant data shows WGS's Enterprise Value at -$170.7 million in Q1 2026, -$171.3 million in Q4 2025, and -$155.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | -3.94 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -4.34 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -196.93 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -1.81 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -1.95 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -1.10 Bn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -1.17 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -51.40 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -323.00 Mn |
| 10 | GeneDx Holdings | 2.08 Bn | 1.94 Bn | 78.24 Mn | -132.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -132.55 Mn |
| Mar 31, 2026 | -170.69 Mn |
| Dec 31, 2025 | -171.28 Mn |
| Sep 30, 2025 | -155.08 Mn |
| Jun 30, 2025 | -134.56 Mn |
| Mar 31, 2025 | -159.16 Mn |
| Dec 31, 2024 | -141.19 Mn |
| Sep 30, 2024 | -116.46 Mn |
| Jun 30, 2024 | -106.86 Mn |
| Mar 31, 2024 | -112.91 Mn |
| Dec 31, 2023 | -130.15 Mn |
| Sep 30, 2023 | -114.29 Mn |
| Jun 30, 2023 | -156.66 Mn |
| Mar 31, 2023 | -214.04 Mn |
| Dec 31, 2022 | -123.93 Mn |
| Sep 30, 2022 | -191.40 Mn |
| Jun 30, 2022 | -284.60 Mn |
| Mar 31, 2022 | -315.00 Mn |
| Dec 31, 2021 | -400.57 Mn |
| Sep 30, 2021 | -461.28 Mn |